Patents by Inventor John Devlin Foley

John Devlin Foley has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • NITRIC OXIDE DONORS FOR USE IN SURGICAL RECOVERY
    Publication number: 20230140515
    Abstract: Disclosed herein are nitric oxide donors and methods of use thereof.
    Type: Application
    Filed: November 2, 2022
    Publication date: May 4, 2023
    Inventor: John Devlin Foley
  • COATED DEVICES AND METHODS OF MAKING COATED DEVICES THAT REDUCE SMOOTH MUSCLE CELL PROLIFERATION AND PLATELET ACTIVITY
    Publication number: 20150190253
    Abstract: The present invention relates generally to the maintenance of blow flood using drug eluting stents and/or other coated medical devices to increased length of time of blood flow. Further, the present invention relates to drug-releasing coated devices for reducing smooth muscle cell proliferation and platelet activity to further limit restenosis utilizing resveratrol and quercetin, polyphenols that are linked to the cardioprotection of red wine consumption. The present invention also provides products and methods for treating or preventing atherosclerosis, stenosis, restenosis, smooth muscle cell proliferation, platelet cell activation and other clotting mechanisms, occlusive disease, or other abnormal lumenal cellular proliferation condition in a location within the body of a patient.
    Type: Application
    Filed: March 20, 2015
    Publication date: July 9, 2015
    Inventors: Tammy R. DUGAS, Alok KHANDELWAL, James John KLEINEDLER, John Devlin FOLEY
  • Coated devices and method of making coated devices that reduce smooth muscle cell proliferation and platelet activity
    Patent number: 8992603
    Abstract: The present invention relates generally to the maintenance of blow flood using drug eluting stents and/or other coated medical devices to increased length of time of blood flow. Further, the present invention relates to drug-releasing coated devices for reducing smooth muscle cell proliferation and platelet activity to further limit restenosis utilizing resveratrol and quercetin, polyphenols that are linked to the cardioprotection of red wine consumption. The present invention also provides products and methods for treating or preventing atherosclerosis, stenosis, restenosis, smooth muscle cell proliferation, platelet cell activation and other clotting mechanisms, occlusive disease, or other abnormal lumenal cellular proliferation condition in a location within the body of a patient.
    Type: Grant
    Filed: October 2, 2012
    Date of Patent: March 31, 2015
    Assignees: Nanocopoeia, Inc., Louisiana State University Health Sciences Center Office of Research
    Inventors: Tammy R. Dugas, Alok Khandelwal, James John Kleinedler, John Devlin Foley
  • Coated devices and method of making coated devices that reduce smooth muscle cell proliferation and platelet activity
    Patent number: 8992471
    Abstract: The present invention relates generally to the maintenance of blow flood using drug eluting stents and/or other coated medical devices to increased length of time of blood flow. Further, the present invention relates to drug-releasing coated devices for reducing smooth muscle cell proliferation and platelet activity to further limit restenosis utilizing resveratrol and quercetin, polyphenols that are linked to the cardioprotection of red wine consumption. The present invention also provides products and methods for treating or preventing atherosclerosis, stenosis, restenosis, smooth muscle cell proliferation, platelet cell activation and other clotting mechanisms, occlusive disease, or other abnormal lumenal cellular proliferation condition in a location within the body of a patient.
    Type: Grant
    Filed: November 5, 2008
    Date of Patent: March 31, 2015
    Assignees: Nanocopoeia, Inc., Louisiana State University Health Sciences Center Office of Research
    Inventors: Tammy R. Dugas, Alok Khandelwal, James John Kleinedler, III, John Devlin Foley
  • COATED DEVICES AND METHOD OF MAKING COATED DEVICES THAT REDUCE SMOOTH MUSCLE CELL PROLIFERATION AND PLATELET ACTIVITY
    Publication number: 20130030518
    Abstract: The present invention relates generally to the maintenance of blow flood using drug eluting stents and/or other coated medical devices to increased length of time of blood flow. Further, the present invention relates to drug-releasing coated devices for reducing smooth muscle cell proliferation and platelet activity to further limit restenosis utilizing resveratrol and quercetin, polyphenols that are linked to the cardioprotection of red wine consumption. The present invention also provides products and methods for treating or preventing atherosclerosis, stenosis, restenosis, smooth muscle cell proliferation, platelet cell activation and other clotting mechanisms, occlusive disease, or other abnormal lumenal cellular proliferation condition in a location within the body of a patient.
    Type: Application
    Filed: October 2, 2012
    Publication date: January 31, 2013
    Applicants: LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER OFFICE OF RESEARCH, NANOCOPOEIA, INC.
    Inventors: Tammy R. DUGAS, Alok KHANDELWAL, James John KLEINEDLER, III, John Devlin FOLEY
  • COATED DEVICES AND METHOD OF MAKING COATED DEVICES THAT REDUCE SMOOTH MUSCLE CELL PROLIFERATION AND PLATELET ACTIVITY
    Publication number: 20100331965
    Abstract: The present invention relates generally to the maintenance of blow flood using drug eluting stents and/or other coated medical devices to increased length of time of blood flow. Further, the present invention relates to drug-releasing coated devices for reducing smooth muscle cell proliferation and platelet activity to further limit restenosis utilizing resveratrol and quercetin, polyphenols that are linked to the cardioprotection of red wine consumption. The present invention also provides products and methods for treating or preventing atherosclerosis, stenosis, restenosis, smooth muscle cell proliferation, platelet cell activation and other clotting mechanisms, occlusive disease, or other abnormal lumenal cellular proliferation condition in a location within the body of a patient.
    Type: Application
    Filed: November 5, 2008
    Publication date: December 30, 2010
    Applicant: NANOCOPOEIA, INC.
    Inventors: Tammy R. Dugas, Alok Khandelwal, James John Kleinedler, III, John Devlin Foley